At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 20 target
Drug / intervention
Type 2 Thyroplasty using Titanium Bridgesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges
In Brief
A Phase 3 clinical trial evaluating Type 2 Thyroplasty using Titanium Bridges for Adductor Spasmodic Dysphonia. Completed, enrolled 20 participants across 4 sites.
Detailed Summary
For adductor spasmodic dysphonia, there is a need for establishing a new therapy under the present circumstance where no standard therapy has been established yet and existing therapies fail to provide permanent effect. Evaluation of the efficacy of type 2 thyroplasty using titanium bridges will expand the therapeutic options available for adductor spasmodic dysphonia and establishment of a standard therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdductor Spasmodic Dysphonia
CountriesJapan
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
First PostedAug 2015
Primary CompletionMar 2017
TodayJul 2026
First PostedAug 19, 2015
Enrollment StartJul 27, 2015
Primary CompletionMar 29, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 10.9 years ago
Interventions
Type 2 Thyroplasty using Titanium Bridgesdevice